Deutsche Bank AG Makes New $3.39 Million Investment in Integer Holdings Corporation $ITGR

Key Points

• Deutsche Bank acquired a new 36,253-share stake in Integer Holdings worth approximately $3.39 million, while institutional investors collectively own 99.29% of the company.
• Integer exceeded quarterly expectations, reporting EPS of $1.60 versus the $1.38 consensus and revenue of $464.11 million, although revenue declined 2.6% year over year.
• Analyst sentiment remains cautious: multiple firms recently downgraded the stock, leaving Integer with an overall “Hold” rating and an average price target of $109.86, below its reported $125.32 share price.

Deutsche Bank AG bought a new stake in shares of Integer Holdings Corporation (NYSE:ITGR - Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 36,253 shares of the medical equipment provider's stock, valued at approximately $3,388,000. Deutsche Bank AG owned 0.11% of Integer as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently made changes to their positions in the stock. Vanguard Group Inc. raised its holdings in shares of Integer by 0.4% during the fourth quarter. Vanguard Group Inc. now owns 3,886,150 shares of the medical equipment provider's stock valued at $304,791,000 after purchasing an additional 14,465 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in Integer by 6.5% in the first quarter. Dimensional Fund Advisors LP now owns 1,484,396 shares of the medical equipment provider's stock worth $130,620,000 after purchasing an additional 90,277 shares during the last quarter. State Street Corp boosted its holdings in Integer by 3.7% in the fourth quarter. State Street Corp now owns 1,371,767 shares of the medical equipment provider's stock worth $107,588,000 after purchasing an additional 48,463 shares during the last quarter. Viking Global Investors LP grew its position in Integer by 9.1% in the 2nd quarter. Viking Global Investors LP now owns 1,283,965 shares of the medical equipment provider's stock worth $157,889,000 after purchasing an additional 106,692 shares during the period. Finally, Irenic Capital Management LP purchased a new stake in Integer during the 4th quarter valued at $99,109,000. Hedge funds and other institutional investors own 99.29% of the company's stock.

Key Stories Impacting Integer

Here are the key news stories impacting Integer this week:

• Positive Sentiment: Zacks raised its FY2026 EPS forecast to $6.13 from $6.05 and increased its estimates for Q2 2027 and Q1 2028 to $1.61 and $1.71, respectively. These upward revisions provide some support for the outlook.
• Neutral Sentiment: Zacks maintained a “Hold” rating on Integer. Its current full-year consensus EPS estimate is approximately $6.08, while the firm projects FY2027 EPS of $6.56 and FY2028 EPS of $6.85, indicating continued earnings growth but limited near-term conviction.
• Negative Sentiment: Zacks reduced estimates for Q3 2026 EPS to $1.63 from $1.68, Q4 2026 EPS to $1.70 from $1.77, Q1 2027 EPS to $1.46 from $1.50, Q3 2027 EPS to $1.72 from $1.87, Q4 2027 EPS to $1.77 from $1.90, FY2027 EPS to $6.56 from $6.87, and FY2028 EPS to $6.85 from $7.20. The broad reductions, particularly to full-year 2027 and 2028 forecasts, are likely the main reason the stock has weakened.

Analyst Ratings Changes

ITGR has been the topic of a number of research reports. Weiss Ratings restated a "hold (c)" rating on shares of Integer in a research note on Thursday, June 18th. HC Wainwright reiterated a "buy" rating on shares of Integer in a research report on Friday, July 24th. Raymond James Financial cut Integer from a "moderate buy" rating to a "hold" rating in a research report on Monday, August 3rd. KeyCorp downgraded Integer from an "overweight" rating to a "sector weight" rating in a report on Monday, August 3rd. Finally, Freedom Capital downgraded Integer from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, August 4th. One analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company's stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $109.86.

Integer Trading Down 0.1%

NYSE:ITGR opened at $125.32 on Thursday. Integer Holdings Corporation has a one year low of $62.00 and a one year high of $126.14. The business has a fifty day moving average price of $106.20 and a 200-day moving average price of $93.99. The firm has a market capitalization of $4.26 billion, a price-to-earnings ratio of 34.24, a price-to-earnings-growth ratio of 2.96 and a beta of 0.61. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41.

Integer (NYSE:ITGR - Get Free Report) last released its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.38 by $0.22. The business had revenue of $464.11 million during the quarter, compared to analyst estimates of $451.07 million. Integer had a return on equity of 12.79% and a net margin of 6.97%.Integer's revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.55 earnings per share. Sell-side analysts forecast that Integer Holdings Corporation will post 6.09 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation NYSE: ITGR is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer's product portfolio is organized into two core segments: Advanced Delivery and MedTech.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source